Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Sirolimus by Biodexa Pharmaceuticals for Prostate Cancer: Likelihood of Approval
Sirolimus is under clinical development by Biodexa Pharmaceuticals and currently in Phase II for Prostate Cancer. According to GlobalData, Phase...
Data Insights
Sirolimus by Biodexa Pharmaceuticals for Familial Adenomatous Polyposis: Likelihood of Approval
Sirolimus is under clinical development by Biodexa Pharmaceuticals and currently in Phase II for Familial Adenomatous Polyposis. According to GlobalData,...